"/>

Supplementary Table S2 from Quantitative Phosphotyrosine Profiling of Patient-Derived Xenografts Identifies Therapeutic Targets in Pediatric Leukemia

crossref(2023)

引用 0|浏览4
暂无评分
摘要

Class I phosphotyrosine (pY) sites of the "Tyrosine Kinases" enriched either in T-ALL (ALL-8, ALL-31) and B-ALL (ALL-17, ALL-19)

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要